World Sleep 2022 | Advances in the genetics and biochemistry of sleep disorders in patients with autism

In this video, Beth Ann Malow, MD, Vanderbilt University, Nashville, TN, shares some insights into recent advances in the genetics and biochemistry of sleep disorders in patients with autism spectrum disorder (ASD). Prof. Malow first emphasizes the importance of making treatment more personalized in ASD using genetic and biochemical information. Following this, Prof. Malow details some examples of how genetic information and clinical observations can be correlated to better understand and treat sleep disorders. To conclude, Prof. Malow discusses some ongoing work at Vanderbilt University, Tennessee, which aims to build a detailed biorepository and use this information to better understand the mechanisms of sleep disorders in ASD. This interview took place during the World Sleep Congress 2022 in Rome, Italy.